SCHEMBL6415898

SCHEMBL6415898

NC(=O)c1cccc(-c2ccc(/C=N/Nc3nc4nonc4nc3Nc3ccccc3)o2)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BIRC5 O15392 1/20 0.66
KDM4E B2RXH2 10/20 0.50
MAPT P10636 9/20 0.50
POLB P06746 7/20 0.50
L3MBTL1 Q9Y468 7/20 0.50
TDP1 Q9NUW8 5/20 0.50
ALDH1A1 P00352 4/20 0.50
GAA P10253 4/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
RAB9A P51151 3/20 0.47
G6PD P11413 1/20 0.47
HTT P42858 1/20 0.47
NPC1 O15118 2/20 0.46
HSP90AA1 P07900 1/20 0.46
LDHA P00338 6/20 0.46
PKM P14618 3/20 0.45
APEX1 P27695 1/20 0.45
BLM P54132 1/20 0.45
HPGD P15428 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6415902 1.00 BIRC5 (0.66) BIRC5KDM4EMAPTPOLBL3MBTL1
SCHEMBL6413417 0.93 BIRC5 (0.76) BIRC5KDM4EMAPTPOLBL3MBTL1
SCHEMBL6507003 0.93 BIRC5 (0.76) BIRC5KDM4EMAPTPOLBL3MBTL1
SCHEMBL6419705 0.92 BIRC5 (0.61) BIRC5KDM4EMAPTPOLBL3MBTL1
SCHEMBL6419708 0.92 BIRC5 (0.61) BIRC5KDM4EMAPTPOLBL3MBTL1
SCHEMBL6416014 0.89 BIRC5 (0.60) BIRC5KDM4EMAPTPOLBL3MBTL1
SCHEMBL6436056 0.89 BIRC5 (0.60) BIRC5KDM4EMAPTPOLBL3MBTL1
SCHEMBL6432659 0.87 BIRC5 (0.59) BIRC5KDM4EMAPTPOLBL3MBTL1
SCHEMBL6432656 0.87 BIRC5 (0.59) BIRC5KDM4EMAPTPOLBL3MBTL1
SCHEMBL6415091 0.87 BIRC5 (0.57) BIRC5KDM4EMAPTPOLBL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050143382-A1 Heterocyclic compounds as pharmaceutically active compounds 4SC AG (DE) 2005-06-30 US disclosed
WO-2005044270-A1 OXADIAZOLOPYRAZINE DERIVATIVES AS PHARMACEUTICALLY ACTIVE COMPOUNDS 4SC AG (DE) 2005-05-19 WO disclosed
EP-1529531-A1 Oxadiazolopyrazine derivatives as pharmaceutically active compounds 4SC AG (DE) 2005-05-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050143382-A1 Heterocyclic compounds as pharmaceutically active compounds NR5A2, NR1H2, NR2C2 BIRC5 2525/4885KDM4E 3277/4885MAPT 4420/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.